Publications
161
Citations
2,543
Est. group size
~6
Recurring co-author estimate
Active years
28
Publishing since 1999
Typically publishes in teams of ~16 · 4% small-team papers (≤3 authors) · across 26 venues
- Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription
Nature Communications · 2026
- Abstract 4776: Lurbinectedin alters EWS::FLI1 binding to chromatin to poison transcription
Cancer Research · 2026
- Data from Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
2026
- Supplemental Table 1 from Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
2026
- Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing Sarcoma
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing Sarcoma
SSRN Electronic Journal · 2026
- Abstract 7805: Development of a GFRA2-targeting antibody drug conjugate for neuroblastoma (NB), and Ewing sarcoma (EWS)
Cancer Research · 2026
- Abstract 635: Defining the intertumoral and intratumoral transcriptional heterogeneity of EWS::FLI1 in Ewing sarcoma.
Cancer Research · 2026
- Comprehensive DSRCT multi‐omics analyses unveil CACNA2D2 as a diagnostic hallmark and super‐enhancer‐driven EWSR1::WT1 signature gene
Cancer Communications · 2025
- Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Journal of Clinical Oncology · 2025
- Advancing Preclinical Biology for Ewing Sarcoma: An International Effort
Molecular Cancer Therapeutics · 2025
- Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children’s Oncology Group
medRxiv · 2025
- Exploiting divergent mechanisms of trabectedin for bone tumors
Molecular Therapy Oncology · 2025
- Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma
Clinical Cancer Research · 2024
- Abstract 1082: Exploiting lurbinectedin-driven nucleolar relocalization of EWS-FLI1 to develop novel combination therapies for Ewing sarcoma
Cancer Research · 2024
- Cancer Research×23
- Journal of Clinical Oncology×6
- Clinical Cancer Research×3
- Molecular Cancer Therapeutics×3
- Pediatric Blood & Cancer×3
- Julia Selich‐Anderson
Medicine · The Ohio State University
- Stephen L. Lessnick
Medicine · The Ohio State University
- Lucia Casadei
Medicine · The Ohio State University
- Elissa A. Boguslawski
Medicine · University of Michigan
- Pankita H. Pandya
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile